In ovarian cancer, KRAS mutation was an increasing trend from normal ovaries to benign mucinous tumors, mucinous borderline tumors, and mucinous ovarian tumors [49,50]. The gene discussed is KRAS; the disease is ovarian mucinous neoplasm.